Comparative analysis of the nephroprotective action of ademetioninee and glutathione in ischemia-reperfusion acute kidney injury

Authors

  • Vera Drachuk Higher State Educational Establishment of Ukraine «Bukovinian State Medical University» Teatralna sq., 2, Chernivtsi, Ukraine, 58002, Ukraine https://orcid.org/0000-0003-3208-7609
  • Igor Zamorskii Higher State Educational Establishment of Ukraine «Bukovinian State Medical University» Teatralna sq., 2, Chernivtsi, Ukraine, 58002, Ukraine https://orcid.org/0000-0003-0947-6729
  • Tetiana Shchudrova Higher State Educational Establishment of Ukraine «Bukovinian State Medical University» Teatralna sq., 2, Chernivtsi, Ukraine, 58002, Ukraine https://orcid.org/0000-0003-4186-2013

DOI:

https://doi.org/10.15587/2519-4852.2018.129694

Keywords:

nephroprotective effect, ademetionine, glutathione, ischemia-reperfusion, acute kidney injury

Abstract

Despite significant advances in drug therapy and improvements in renal replacement therapy, mortality rate of acute kidney injury (AKI) continuously increases and is about 25-70 %. Ischemia-reperfusion AKI is not an exception with its multifactorial pathogenesis and rapid progressive development, usually resulting from trauma, sepsis, kidney transplantation, or an influence of toxic substances. For this reason, drugs with potent cytoprotective and antioxidant activity – ademetionine and glutathione have drawn our attention as remedies for the pathogenetic correction of ischemia-reperfusion AKI.

Aim. To compare the influence of ademetionine and glutathione on the functional state and antioxidant balance in kidneys of rats with ischemia-reperfusion AKI.

Methods. Research was conducted on 28 mature non-linear white rats weighting 130-180 g, randomly divided into 4 groups (n = 7): I group – control (pseudo-operated animals), II group – modeling of ischemia-reperfusion kidney injury (I/R), III group –administration of ademetionine (Heptral, “Abbott SpA”, Italy) at a dose of 20 mg/kg prior to I/R modeling, animals of IV group were daily injected with glutathione (TAD 600, “Biomedica Foscama”, Italy) at a dose of 30 mg/kg. Functional state and histological changes in kidneys was estimated after 24 hours of reperfusion by the indices of diuresis, GFR, urine protein excretion, excretion of sodium and potassium ions with urine. Peroxidation processes in kidneys were evaluated by the malone dialdehyde and oxidative modification of proteins levels, antioxidant defense – by catalase and glutathione peroxidase activity. Histological examination was conducted by hematoxylin and eosin staining of kidney tissue sections.

Results. It was established the use of studied drugs in I/R AKI ameliorated excretory kidney function of rats, which was realized in an increase in GFR and diuresis with simultaneous decrease in azotemia and proteinuria. It was accompanied by a restoration of ion-regulatory kidney function, confirmed by an increase in sodium reabsorption with recovery of proximal and distal tubular transport. Analysis of antioxidant system shows an inhibition of lipid peroxidation processes on the background of antioxidant system activation with significantly better effect of glutathione, which was confirmed by the histological study.

Conclusion. As it is shown, both ademetionine and glutathione exhibit nephroprotective effect in rats with ischemia-reperfusion acute kidney injury. At the same time, effect of glutathione administration significantly exceeds that of ademetionine by the restoration of the functional state of nephrons as well as the effect on the prooxidant - antioxidant balance in renal tissue, which is confirmed by the histological study. Obtained results give a background for the further research of nephroprotective potential of the ademetionine and glutathione in conditions of AKI of different etiology

Author Biographies

Vera Drachuk, Higher State Educational Establishment of Ukraine «Bukovinian State Medical University» Teatralna sq., 2, Chernivtsi, Ukraine, 58002

Аssistant

Department of Pharmacology

Igor Zamorskii, Higher State Educational Establishment of Ukraine «Bukovinian State Medical University» Teatralna sq., 2, Chernivtsi, Ukraine, 58002

MD, Professor

Department of Pharmacology

Tetiana Shchudrova, Higher State Educational Establishment of Ukraine «Bukovinian State Medical University» Teatralna sq., 2, Chernivtsi, Ukraine, 58002

PhD, Associate Professor

Department of Pharmacology

References

  1. Komissarov, K. S., Pilotovich, V. S., Yurkevich, M. Yu. et. al. (2015). Tekhnicheskie osobennosti eksperimental'noy modeli ostrogo ishemicheski-reperfuzionnogo povrezhdeniya pochek. Novosti hirurgii, 23 (3), 262–267.
  2. Vatazin, A. V., Nesterenko, I. V., Zulkarnaev, A. B., Shakhov, N. L. (2015). Pathogenetic mechanisms of the development of ischemic and reperfusion damage the kidneys as a promising target specific therapy. Russian Journal of Transplantology and Artificial Organs, 17 (1), 147–156. doi: 10.15825/1995-1191-2015-1-147-156
  3. Shchudrova, T. S., Zamorskyi, I. I. (2015). Mekhanizmy realizatsiyi zakhysnoho vplyvu deiakykh olihopeptydiv pry ishemiyi-reperfuziyi nyrok. Odeskyi medychnyi zhurnal, 3, 7–10. Available at: http://nbuv.gov.ua/UJRN/Omj_2015_3_3
  4. Andrusev, K. S. (2014). Ostroe pochechnoe povrezhdenie. Klinicheskie prakticheskie rekomendatsii KDIGO (osnovnye polozheniya). Nefrologiya i dializ, 14 (2), 86–94.
  5. Sancaktutar, A., Bodakci, M., Hatipoglu, N., Basarılı, K., Soylemez, H., Turkcu, G. (2014). The protective effects of pomegranate extracts against renal ischemia-reperfusion injury in male rats. Urology Annals, 6 (1), 46. doi: 10.4103/0974-7796.127029
  6. Yur'ev, K. L. (2012). Geptral (ademetionin) – gepatoprotektor i antidepresant. Ukr. med. Chasopis, 1 (87), 10–16. URL: http://www.umj.com.ua/article/28041
  7. Zvyagintseva, T. D., Chernobay, A. I., Glushchenko, S. V. (2014). Rol' ademetionina v razvitii i progressirovanii hronicheskih zabolevaniy pecheni. Ukr. med. chasopis, 3 (101).
  8. Anstee, Q. M., Day, C. P. (2012). S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility. Journal of Hepatology, 57 (5), 1097–1109. doi: 10.1016/j.jhep.2012.04.041
  9. Bharadwaj, A., Bydoun, M., Holloway, R., Waisman, D. (2013). Annexin A2 Heterotetramer: Structure and Function. International Journal of Molecular Sciences, 14 (3), 6259–6305. doi: 10.3390/ijms14036259
  10. GEPTRAL. Available at: http://mozdocs.kiev.ua/likiview.php?id=31805
  11. Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A. et. al. (2013). Role of Glutathione in Cancer Progression and Chemoresistance. Oxidative Medicine and Cellular Longevity, 2013, 1–10. doi: 10.1155/2013/972913
  12. Salyha, N. O. (2013). Aktyvnist hlutationovoi systemy antyoksydantnoho zakhystu v shchuriv za diyi L-hlutaminovoi kysloty. Ukr. biokhim. zhurn., 85 (4), 40–47.
  13. Shumeiko, V. M., Sharykina, N. I., Khavych, O. O., Shumeiko, M. V. (2009). Zastosuvannia metodiv shvydkoi ekstrapoliatsiyi u farmakolohichnykh doslidzhenniakh. Farmakolohiia ta likarska toksykolohiya, 4 (11), 39–41.
  14. Arakelyan, N. G., Shtrigol', S. Yu. (2007). Pat. No. 28140 UA. Zastosuvannya meksikolu yak nefroprotektornogo zasobu. MPK (2006) A61K 31/4425. No. u200708435; declareted: 23.07.2007; published: 26.11.2007, Bul. No. 19, 4.
  15. Shtryhol, S. Yu., Lisovyi, V. M., Zupanets, I. A. et. al. (2009). Metody eksperymentalnoho modeliuvannia urazhennia nyrok pry farmakolohichnykh doslidzhenniakh: Metodychni rekomendatsiyi DFTs Ukrainy. Kyiv, 9–10.
  16. Kamyshnikov, V. S. (2009). Spravochnik po kliniko-biohimicheskim issledovaniyam i laboratornoy diagnostike. Moscow, 880.
  17. Mahalias, V. M., Mykhieiev, A. O., Rohovyi, Yu. Ye. (2001). Suchasni metodyky eksperymentalnykh ta klinichnykh doslidzhen tsentralnoi naukovo-doslidnoi laboratoriyi BDMA. Chernivtsi: BDMA, 42.
  18. Ryabov, S. I., Natochin, Yu. V. (1997). Funktsional'naya nefrologiya. Sankt-Peterburg: Lan', 304.
  19. Stal'naya, I. D., Garishvili, T. G. (1997). Metod opredeleniya malonovogo dial'degida s pomoshch'yu tiobarbiturovoy kisloty. Sovremennye metody v biohimii. Moscow: Meditsina, 66–68.
  20. Meshchyshen, I. F. (1998). Metod vyznachennia okysliuvalnoi modyfikatsiyi bilkiv plazmy (syrovatky) krovi. Bukovynskyi medychnyi visnyk, 2 (1), 156–158.
  21. Korolyuk, M. A., Ivanova, L. I., Mayorova, I. G. et. al. (1988). Metod opredeleniya aktivnosti katalazy. Laboratornoe delo, 1, 16–19.
  22. Arutyunyan, A. V., Dubinina, E. E., Zybina, N. N. (2000). Metody otsenki svobodnoradikal'nogo okisleniya i antioksidantnoy sistemy organizma. Metodicheskie rekomendatsii. Sankt-Peterburg: IKF «Foliant», 104.
  23. Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes (2010). Official Journal of the European Union, 53 (276), 33–80.

Downloads

Published

2018-04-27

How to Cite

Drachuk, V., Zamorskii, I., & Shchudrova, T. (2018). Comparative analysis of the nephroprotective action of ademetioninee and glutathione in ischemia-reperfusion acute kidney injury. ScienceRise: Pharmaceutical Science, (2 (12), 49–55. https://doi.org/10.15587/2519-4852.2018.129694

Issue

Section

Pharmaceutical Science